ACTELION LTD (ALIOF)

280.25
1.00 0.36
Prev Close 279.25
Open 279.75
Day Low/High 279.50 / 280.75
52 Wk Low/High 135.00 / 286.20
Volume 7.09K
Exchange n.a.
Shares Outstanding 107.33B
Market Cap 29.89B
Div & Yield N.A. (N.A)

Latest News

Johnson & Johnson Buys Actelion for $30 Billion

Johnson & Johnson Buys Actelion for $30 Billion

Johnson & Johnson plans to spin out Actelion's research and development unit into a separate business.

Global Stocks Are Following Wall Street Higher as Dow Hits 20,000

Global Stocks Are Following Wall Street Higher as Dow Hits 20,000

The Dow Jones Industrial Average took almost 103 years to reach 10,000 in March 1999 and nearly 18 more years to reach 20,000.

Johnson & Johnson CEO Talks Trump, Taxes and M&A After Mixed Earnings

Johnson & Johnson CEO Talks Trump, Taxes and M&A After Mixed Earnings

CEO Alex Gorsky dishes on Monday's meeting with President Trump during Johnson & Johnson's conference call.

Dow on Track for Sixth Straight Week of Gains Even as Markets Fall

Dow on Track for Sixth Straight Week of Gains Even as Markets Fall

The Dow Jones Industrial Average held slight weekly gains on Friday afternoon even in a down day for Wall Street.

Dow Eyes 20,000 as Stocks Drift Higher

Dow Eyes 20,000 as Stocks Drift Higher

Stocks rise on Friday, putting the Dow Jones Industrial Average one step closer to the psychologically important 20,000 level.

5 Things You Must Know Before the Market Opens Friday

5 Things You Must Know Before the Market Opens Friday

U.S. stock futures are mixed while the dollar surges as global markets adjust to higher U.S. interest rates; Facebook plans to fact-check its news; Adobe's earnings top forecasts.

European Stocks Drift Lower; Dollar Dominates Global Financial Markets

European Stocks Drift Lower; Dollar Dominates Global Financial Markets

European stocks are set to book another solid weekly advance amid global market adjustments to the new Fed outlook.

Actelion Stock Hits Record High on Speculation of Sanofi Takeover Approach

Actelion Stock Hits Record High on Speculation of Sanofi Takeover Approach

Actelion stocks surged higher in Zurich amid speculation that France's Sanofi may make a formal approach for the Swiss biotech.

Johnson & Johnson Looks for New Deal That's Just Right

Johnson & Johnson Looks for New Deal That's Just Right

Actelion was too pricey. Now J&J is looking for another acquisition.

Actelion's Independent Streak Gives Rise to Doubt That Sanofi Will Fill the Breach

Actelion's Independent Streak Gives Rise to Doubt That Sanofi Will Fill the Breach

Shares in Europe's biggest biotech fall 9%, to a 25% discount to J&J's rumored bid, while Sanofi declines to comment on reports it is in talks.

Actelion Is a Perfect Fit for Sanofi, but Probably Too Expensive: Exane BNP

Actelion Is a Perfect Fit for Sanofi, but Probably Too Expensive: Exane BNP

The chances of the French drug company muscling in on Johnson & Johnson's talks with Actelion are slim, based on Sanofi's cost of capital vs. return from a possible deal.

5 Things You Must Know Before the Market Opens Monday

5 Things You Must Know Before the Market Opens Monday

U.S. stock futures point lower as crude oil gyrates after Saudi Arabia pulls out of a meeting Monday with Russia and other large non-OPEC producers.

J&J's Actelion Deal Just One More Reason to Buy Shares

J&J's Actelion Deal Just One More Reason to Buy Shares

Johnson & Johnson has some of the world's best-known health and personal care brands, while Actelion manufactures popular treatments for pulmonary arterial hypertension.

European Markets Close at One-Month High Despite Oil Decline

European Markets Close at One-Month High Despite Oil Decline

European markets closed higher for the third week running, led by Johnson & Johnson target Actelion, while oil contractors fell along with the price of Brent crude oil.

Wall Street Notches New Records in Quiet Post-Thanksgiving Trade

Wall Street Notches New Records in Quiet Post-Thanksgiving Trade

Wall Street hit new highs on Friday in a half-day session after the Thanksgiving holiday.

Dow, S&P 500 Set for Record Closes in Light Black Friday Session

Dow, S&P 500 Set for Record Closes in Light Black Friday Session

Stocks edge higher on Friday, on track to post another record session, in a quieter session after the Thanksgiving holiday in the U.S.

Stock Futures Hold Higher on a Quiet Black Friday, Trade Deficit Widens

Stock Futures Hold Higher on a Quiet Black Friday, Trade Deficit Widens

Stock futures edge higher on Friday, on track to post another record session, in a quieter session after the Thanksgiving holiday.

5 Things You Must Know Before the Market Opens Friday

5 Things You Must Know Before the Market Opens Friday

Target sees a surge in online traffic on Thanksgiving; U.S. stock futures suggest the Dow will open at another record high; J&J reportedly is bidding for Switzerland's Actelion.

European Stocks Mixed, Bonds Active in Post Thanksgiving Trading

European Stocks Mixed, Bonds Active in Post Thanksgiving Trading

European stocks fell in the first hour of trading amid a strong U.S. dollar and rising bond yields.

Actelion Soars as Johnson & Johnson 'Makes Takeover Proposal'

Actelion Soars as Johnson & Johnson 'Makes Takeover Proposal'

The Swiss biotech was last year reported to be a target of Shire.

Relypsa Seen As Next Target After Astra Buys ZS

Relypsa Seen As Next Target After Astra Buys ZS

Shares of ZS Pharma are surging after the development stage drugmaker agreed to be acquired by pharmaceutical giant AstraZeneca in a $2.7B deal.

European Stocks Sink Despite Deutsche Bank Shakeup, BT Deal Talk

European Stocks Sink Despite Deutsche Bank Shakeup, BT Deal Talk

There's plenty of action in European markets Monday, despite continued nervousness about negotiations with Greece and some downsizing of expectations on the British economy.

Concerns Over Interest Rates Persist, Investors Should Stick With Health Care

Concerns Over Interest Rates Persist, Investors Should Stick With Health Care

The CNBC 'Fast Money Halftime' traders dissect the anticipation of an interest rate hike, and say investors may be best off sticking with clear winners like health care stocks.

Biotechs Rise After InterMune Acquired by Roche

Biotechs Rise After InterMune Acquired by Roche

Shares of a number of biopharmaceutical companies are climbing after drug maker Roche agreed to buy its smaller peer, Intermune, developer of treatments for respiratory and orphan fibrotic diseases.

European Stocks Rebound as EU Meets to Discuss Russia Sanctions

European Stocks Rebound as EU Meets to Discuss Russia Sanctions

European stocks rebound Tuesday, as EU foreign ministers gather in Brussels to discuss whether to increase sanctions against Russia.

Myogen Critics Chop Liver Data

Myogen Critics Chop Liver Data

Some question whether Myogen's heart drug is as safe as the numbers say it is.